Literature DB >> 21327852

Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study.

Kazumasa Kume1, Haruo Hanyu, Tomohiko Sato, Kentaro Hirao, Soichiro Shimizu, Hidekazu Kanetaka, Hiofumi Sakurai, Toshihiko Iwamoto.   

Abstract

We investigated the effects of cardiovascular risk factors, such as hypertension, diabetes mellitus, and hypercholesterolemia, on longitudinal regional cerebral blood flow (rCBF) changes in Alzheimer's disease (AD). We followed 68 outpatients with probable AD for an average of 40 months. They were divided into three groups based on no (n = 24), single (n = 27), and multiple (n = 17) vascular risk factors. We assessed longitudinal changes on the Mini-Mental State Examination, Functional Assessment Staging scores, and in rCBF deficits using repeated single photon emission computed tomography (SPECT) using N-isopropyl-p-[(123)I] iodoamphetamine. During follow-up, the multiple vascular risk factor group showed faster cognitive and functional decline than the no and single vascular risk factor groups. When compared with the initial SPECT, the follow-up SPECT showed a significant rCBF reduction in widespread regions, including the parietotemporal, frontal, and limbic lobes, in the multiple and single vascular risk factor groups, while there was rCBF reduction in small scattered regions of the temporoparietal lobe in the no vascular risk factor group. Multiple vascular risk factors are associated with a greater rate of decline in cognition, function, and rCBF in patients with AD. Our results highlight the contribution of vascular risk factors on the progression of AD.

Entities:  

Mesh:

Year:  2011        PMID: 21327852     DOI: 10.1007/s00415-011-5927-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Authors:  G Li; E B Larson; J A Sonnen; J B Shofer; E C Petrie; A Schantz; E R Peskind; M A Raskind; J C S Breitner; T J Montine
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

3.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

4.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

5.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.

Authors:  I L Notkola; R Sulkava; J Pekkanen; T Erkinjuntti; C Ehnholm; P Kivinen; J Tuomilehto; A Nissinen
Journal:  Neuroepidemiology       Date:  1998       Impact factor: 3.282

6.  Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Authors:  Timothy Kleiman; Kristina Zdanys; Benjamin Black; Tracy Rightmer; Monique Grey; Katherine Garman; Martha Macavoy; Joel Gelernter; Christopher van Dyck
Journal:  Dement Geriatr Cogn Disord       Date:  2006-05-12       Impact factor: 2.959

7.  Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

Authors:  K Ishii; F Willoch; S Minoshima; A Drzezga; E P Ficaro; D J Cross; D E Kuhl; M Schwaiger
Journal:  J Nucl Med       Date:  2001-04       Impact factor: 10.057

8.  Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.

Authors:  Francesco Roselli; Bruno Tartaglione; Francesco Federico; Vito Lepore; Giovanni Defazio; Paolo Livrea
Journal:  Clin Neurol Neurosurg       Date:  2008-11-25       Impact factor: 1.876

9.  Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

Authors:  S Minoshima; R A Koeppe; K A Frey; D E Kuhl
Journal:  J Nucl Med       Date:  1994-09       Impact factor: 10.057

10.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study.

Authors:  T Yoshitake; Y Kiyohara; I Kato; T Ohmura; H Iwamoto; K Nakayama; S Ohmori; K Nomiyama; H Kawano; K Ueda
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  15 in total

1.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

2.  Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion.

Authors:  Jie Qu; Qiong Zhou; Ying Du; Wei Zhang; Miao Bai; Zhuo Zhang; Ye Xi; Zhuyi Li; Jianting Miao
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 3.  CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.

Authors:  Hanna Rosenmann
Journal:  J Mol Neurosci       Date:  2011-11-05       Impact factor: 3.444

4.  Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.

Authors:  Richard Sherva; Yorghos Tripodis; David A Bennett; Lori B Chibnik; Paul K Crane; Philip L de Jager; Lindsay A Farrer; Andrew J Saykin; Joshua M Shulman; Adam Naj; Robert C Green
Journal:  Alzheimers Dement       Date:  2013-03-25       Impact factor: 21.566

Review 5.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

Review 6.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

Review 7.  The dementia of cardiac disease.

Authors:  Hurmina Muqtadar; Fernando D Testai; Philip B Gorelick
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

8.  Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.

Authors:  Azadeh Sayad; Mehrdad Noruzinia; Mahdi Zamani; Mohammad Hossein Harirchian; Anoshirvan Kazemnejad
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

9.  Vascular function, cerebral cortical thickness, and cognitive performance in middle-aged Hispanic and non-Hispanic Caucasian adults.

Authors:  Evan P Pasha; Sonya S Kaur; Mitzi M Gonzales; Daniel R Machin; Kennon Kasischke; Hirofumi Tanaka; Andreana P Haley
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-26       Impact factor: 3.738

10.  Alzheimer's disease with vascular component: a distinct clinical entity?

Authors:  Javier Olazarán; Eloísa Navarro; José Manuel Rojo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.